The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 7, 1999, Pages 921-926

  Peters, F T M ^a   Kuipers, E J ^b   Ganesh, S ^c   Sluiter, W J ^a   Klinkenberg Knol, E C ^b   Lamers, C B H W ^c   Kleibeuker, J H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; IMMUNOGLOBULIN G; OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID; SYMPTOM;

ADULT; AGED; BARRETT ESOPHAGUS; DOUBLE-BLIND METHOD; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMPS; RANITIDINE; SEVERITY OF ILLNESS INDEX;

EID: 0033062287     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00556.x     Document Type: Article

References (17)

1. Newton M, Bryan R, Burnham WR, et al. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 1997; 40: 9-13.
2. Csendes A, Smok G, Cerda G, et al. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflx, erosive esophagitis or Barrett's esophagus. Dis Esophagus 1997; 10: 38-42.
3. Werdmuller BFM, Loffeld RJLF. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42: 103-5.
4. Hackelsberger A, Schultze V, Günther T, et al. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study. Eur J Gastroenterol Hepatol 1998; 10: 465-8.
5. Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-7.
6. + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 588-90.
7. Labenz J, Blum AL, Bayerdörffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
8. Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
9. Labens J, Tillenburg B, Peitz U, et al. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41: 33-6.
10. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476-80.
11. Peña AS, Endtz HP, Offerhaus GJA, et al. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989; 44: 131-41.
12. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastro-esophageal reflux disease. Am J Gastroenterol 1999; in press.
13. Talley NJ, Janssens J, Lauritsen K, et al. No increase of reflux symptoms or esophagitis in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial. Gastroenterology 1998; 114: A306(Abstract).
14. Malfertheiner P, Veldhuyzen van Zanten S, Dent J, et al. Does cure of Helicobacter pylori infection induce heartburn? Gastroenterology 1998; 114: A212(Abstract).
15. Verdú EF, Armstrong D, Idström J-P, et al. Intragastric pH during treatment with omeprazole: role of Helicobacter pylori and H. pylori-associated gastritis. Scand J Gastroenterol 1996; 31: 1151-6.
16. Labenz J, Tillenburg B, Peitz U, et al. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol 1997; 92: 576-81.
17. Hatlebakk JG, Berstad A. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis. Scand J Gastroenterol 1996; 31: 954-8.